817 related articles for article (PubMed ID: 28701207)
1. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
[TBL] [Abstract][Full Text] [Related]
2. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
[TBL] [Abstract][Full Text] [Related]
3. Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Henley JK; Ashchyan HJ; Kurta AO; Patel PM; Sheikh UA; Franklin MJ; Hanna CC; Chen BR; Chiren SG; Schmitt J; Deckert S; Furlan KC; Poon E; Maher IA; Cartee TV; Sobanko JF; Alam M
Trials; 2017 Aug; 18(1):359. PubMed ID: 28764734
[TBL] [Abstract][Full Text] [Related]
4. Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Iyengar S; Williamson PR; Schmitt J; Johannsen L; Maher IA; Sobanko JF; Cartee TV; Schlessinger D; Poon E; Alam M
Trials; 2016 Sep; 17(1):429. PubMed ID: 27580586
[TBL] [Abstract][Full Text] [Related]
5. Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE).
Healy P; Gordijn S; Ganzevoort W; Beune I; Baschat A; Khalil A; Kenny L; Bloomfield F; Daly M; Papageorghiou A; Devane D
Trials; 2018 Aug; 19(1):451. PubMed ID: 30134949
[TBL] [Abstract][Full Text] [Related]
6. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
[TBL] [Abstract][Full Text] [Related]
7. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
[TBL] [Abstract][Full Text] [Related]
8. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
Trials; 2014 Dec; 15():511. PubMed ID: 25540987
[TBL] [Abstract][Full Text] [Related]
9. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'.
Prinsen CA; Vohra S; Rose MR; King-Jones S; Ishaque S; Bhaloo Z; Adams D; Terwee CB
Trials; 2014 Jun; 15():247. PubMed ID: 24962012
[TBL] [Abstract][Full Text] [Related]
10. Outcomes for Pressure Ulcer Trials (OUTPUTs): protocol for the development of a core domain set for trials evaluating the clinical efficacy or effectiveness of pressure ulcer prevention interventions.
Lechner A; Kottner J; Coleman S; Muir D; Bagley H; Beeckman D; Chaboyer W; Cuddigan J; Moore Z; Rutherford C; Schmitt J; Nixon J; Balzer K
Trials; 2019 Jul; 20(1):449. PubMed ID: 31331366
[TBL] [Abstract][Full Text] [Related]
11. Core outcomes in periodontal trials: study protocol for core outcome set development.
Lamont TJ; Clarkson JE; Ricketts DNJ; Heasman PA; Ramsay CR
Trials; 2017 Sep; 18(1):436. PubMed ID: 28931440
[TBL] [Abstract][Full Text] [Related]
12. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.
Harman NL; Wilding J; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
Trials; 2018 Aug; 19(1):427. PubMed ID: 30086771
[TBL] [Abstract][Full Text] [Related]
13. Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer.
Fish R; Sanders C; Williamson PR; Renehan AG
BMJ Open; 2017 Nov; 7(11):e018726. PubMed ID: 29170292
[TBL] [Abstract][Full Text] [Related]
14. A core outcomes set for clinical trials of interventions for young adults with type 1 diabetes: an international, multi-perspective Delphi consensus study.
Byrne M; O'Connell A; Egan AM; Dinneen SF; Hynes L; O'Hara MC; Holt RIG; Willaing I; Vallis M; Hendrieckx C; Coyne I
Trials; 2017 Dec; 18(1):602. PubMed ID: 29258565
[TBL] [Abstract][Full Text] [Related]
15. Development of a core outcome set (COS) and selecting outcome measurement instruments (OMIs) for non-valvular atrial fibrillation in traditional Chinese medicine clinical trials: study protocol.
Qiu R; Li M; Zhang X; Chen S; Li C; Shang H
Trials; 2018 Oct; 19(1):541. PubMed ID: 30290840
[TBL] [Abstract][Full Text] [Related]
16. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).
Kirkham JJ; Gorst S; Altman DG; Blazeby J; Clarke M; Devane D; Gargon E; Williamson PR;
Trials; 2015 Aug; 16():373. PubMed ID: 26297658
[TBL] [Abstract][Full Text] [Related]
17. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.
Lang KM; Harrison KL; Williamson PR; Huntly BJP; Ossenkoppele G; Geissler J; Bereczky T; Hernández-Rivas JM; Chevrou-Séverac H; Goodbody R; Schulze-Rath R; Bullinger L
Trials; 2020 May; 21(1):437. PubMed ID: 32460828
[TBL] [Abstract][Full Text] [Related]
18. Surgical Handover Core Outcome Measures (SH-CORE): a protocol for the development of a core outcome set for trials in surgical handover.
Ryan JM; Devane D; Simiceva A; Eppich W; Kavanagh DO; Cullen C; Hogan AM; McNamara DA
Trials; 2024 Jun; 25(1):373. PubMed ID: 38858749
[TBL] [Abstract][Full Text] [Related]
19. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.
Tallouzi MO; Mathers JM; Moore DJ; Murray PI; Bucknall N; Blazeby JM; Calvert M; Denniston AK
Trials; 2017 Dec; 18(1):576. PubMed ID: 29191216
[TBL] [Abstract][Full Text] [Related]
20. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
